Alpine Immune Sciences, Inc.
(NASDAQ GM: ALPN)
Rigrodsky Law, P.A. is investigating Alpine Immune Sciences, Inc. (“Alpine”) regarding possible breaches of fiduciary duties and other violations of law related to Alpine’s agreement to be acquired by Vertex Pharmaceuticals Incorporated. Under the terms of the agreement, Alpine shareholders will receive $65.00 per share in cash.